Cancer vaccines must induce immune cells, called CD8 + T cells, that can recognize cancer cells over the long term. In pancreatic cancer, a common and deadly cancer, RNA vaccines that ...

A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary study published Wednesday in the journal Nature. Pancreatic cancer ...

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center.

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

Researchers at Oregon Health & Science University have developed a new blood test that they say is able to detect pancreatic ...

Toni Bravo thought she was having an anxiety attack a couple weeks before finals at the University of Notre Dame last year.

The cancer vaccine market is anticipated to experience substantial growth in the coming years. This growth is driven by the rising number of cancer diagnoses, heightened awareness of cancer vaccines, ...